Showing 1 - 7 results of 7 for search 'Edita Baltruskeviciene', query time: 0.04s Refine Results
  1. 1
    Survival and time interval from surgery to the start of chemotherapy for patients with stage II and III colon cancer

    Survival and time interval from surgery to the start of chemotherapy for patients with stage II and III colon cancer by Denis Ganenko, Audrius Dulskas, Žygimantas Kuliešius, Edita Baltruškevičienė, Vincas Urbonas, Eugenijus Stratilatovas

    Published 2019-01-01
    Get full text
    Article
  2. 2
    Significance of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer patients receiving Bevacizumab: a single institution experience

    Significance of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer patients receiving Bevacizumab: a single institution experience by Edita Baltruškevičienė, Ugnius Mickys, Tadas Žvirblis, Rokas Stulpinas, Teresė Pipirienė Želvienė, Eduardas Aleknavičius

    Published 2016-04-01
    Get full text
    Article
  3. 3
    Development of a Cardio-Oncology Service in Lithuania: Prediction, Prevention, Monitoring and Treatment of Cancer Treatment-Induced Cardiotoxicity

    Development of a Cardio-Oncology Service in Lithuania: Prediction, Prevention, Monitoring and Treatment of Cancer Treatment-Induced Cardiotoxicity by Eglė Čiburienė, Sigita Aidietienė, Greta Ščerbickaitė, Birutė Brasiūnienė, Monika Drobnienė, Edita Baltruškevičienė, Tadas Žvirblis, Jelena Čelutkienė

    Published 2022-04-01
    Get full text
    Article
  4. 4
    Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding

    Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding by Edita Baltruskeviciene, Diana Schveigert, Vaidotas Stankevicius, Ugnius Mickys, Tadas Zvirblis, Jaroslav Bublevic, Kestutis Suziedelis, Eduardas Aleknavicius

    Published 2017-09-01
    Get full text
    Article
  5. 5
    Ivabradine for the Prevention of Anthracycline-Induced Cardiotoxicity in Female Patients with Primarily Breast Cancer: A Prospective, Randomized, Open-Label Clinical Trial

    Ivabradine for the Prevention of Anthracycline-Induced Cardiotoxicity in Female Patients with Primarily Breast Cancer: A Prospective, Randomized, Open-Label Clinical Trial by Eglė Čiburienė, Sigita Aidietienė, Greta Ščerbickaitė, Eglė Sadauskienė, Diana Sudavičienė, Edita Baltruškevičienė, Birutė Brasiūnienė, Monika Drobnienė, Jelena Čelutkienė

    Published 2023-12-01
    Get full text
    Article
  6. 6
    High Protein Oral Nutritional Supplements Enable the Majority of Cancer Patients to Meet Protein Intake Recommendations during Systemic Anti-Cancer Treatment: A Randomised Controlled Parallel-Group Study

    High Protein Oral Nutritional Supplements Enable the Majority of Cancer Patients to Meet Protein Intake Recommendations during Systemic Anti-Cancer Treatment: A Randomised Controll... by Anne-Marie Dingemans, Nico van Walree, Franz Schramel, Magdolen Youssef-El Soud, Edita Baltruškevičienė, Willem Lybaert, Margriet Veldhorst, Claudia. A. van den Berg, Stein Kaasa

    Published 2023-12-01
    Get full text
    Article
  7. 7
    Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patients with peritoneal metastases: single-arm phase II study

    Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patient... by Martynas Luksta, Augustinas Bausys, Klaudija Bickaite, Rokas Rackauskas, Marius Paskonis, Raminta Luksaite-Lukste, Anastasija Ranceva, Rokas Stulpinas, Birute Brasiuniene, Edita Baltruskeviciene, Nadezda Lachej, Rasa Sabaliauskaite, Rimantas Bausys, Skaiste Tulyte, Kestutis Strupas

    Published 2023-10-01
    Get full text
    Article

Search Tools: